CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
28.71
0.28%
Market Trading Hours* (UTC) Open now
Closes on Wednesday at 21:00

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.16
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.024346 %
Charges from full value of position ($-4.63)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.024346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.002124 %
Charges from full value of position ($0.40)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.002124%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 28.79
Open 28.62
1-Year Change 54.62%
Day's Range 28.47 - 28.84
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 17, 2024 28.79 0.27 0.95% 28.52 28.97 28.40
Dec 16, 2024 28.77 0.14 0.49% 28.63 29.30 28.39
Dec 13, 2024 28.81 -0.29 -1.00% 29.10 29.11 28.46
Dec 12, 2024 29.29 -0.33 -1.11% 29.62 29.84 29.23
Dec 11, 2024 29.85 0.54 1.84% 29.31 30.34 29.31
Dec 10, 2024 29.70 1.26 4.43% 28.44 30.09 28.44
Dec 9, 2024 28.95 -0.42 -1.43% 29.37 29.37 28.31
Dec 6, 2024 29.47 0.04 0.14% 29.43 29.66 28.78
Dec 5, 2024 29.28 -0.22 -0.75% 29.50 29.65 28.94
Dec 4, 2024 29.41 0.51 1.76% 28.90 29.92 28.90
Dec 3, 2024 29.61 0.37 1.27% 29.24 29.61 28.86
Dec 2, 2024 29.48 0.14 0.48% 29.34 29.87 28.93
Nov 29, 2024 29.55 0.63 2.18% 28.92 29.62 28.81
Nov 27, 2024 29.00 0.50 1.75% 28.50 29.15 28.32
Nov 26, 2024 28.46 0.50 1.79% 27.96 28.60 27.59
Nov 25, 2024 28.26 0.24 0.86% 28.02 28.80 28.02
Nov 22, 2024 28.18 0.32 1.15% 27.86 28.67 27.86
Nov 21, 2024 27.82 0.99 3.69% 26.83 28.31 26.66
Nov 20, 2024 27.02 0.45 1.69% 26.57 27.21 26.34
Nov 19, 2024 26.75 1.04 4.05% 25.71 26.92 25.71

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Artivion Inc Company profile

About Artivion Inc

Artivion, Inc. (Artivion), formerly CryoLife, Inc., is a medical device company. The Company is focused on developing various solutions that address cardiac and vascular surgeons' challenges in treating patients with aortic diseases. The Company's four groups of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts, and surgical sealants. Artivion's cryopreserved cardiac and vascular allograft tissues help in restoring surgeries for adults and pediatric patients. It offers surgical sealant through BioGlue product. Its surgical aortic valve replacement solutions include On-X Aortic Heart Valves and CryoValve SG Pulmonary Valve Allograft for the Ross procedure. The Company's mitral valve solutions include Chord-X for mitral valve repair and On-X Mitral Heart Valve. Artivion's Cardiac and Vascular Ancillary solutions provide complementary support for the patient's cardiac and vascular surgical procedures.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Artivion Inc revenues increased 18% to $298.8M. Net loss applicable to common stockholders decreased 11% to $14.7M. Revenues reflect Medical Devices segment increase of 24% to $221.6M, Preservation services segment increase of 4% to $77.2M, International segment increase of 28% to $147.7M, United States segment increase of 9% to $151.2M.

Equity composition

Common Stock $.01 Par, 03/11, 75M auth., 29,950,000 issd., less 2,053,000 shares in Treas. @ $11.7M. Insiders own 6.85% . IPO 2/93, 1.5M shs @ $10 by Robinson-Humphrey. PO 4/98, 2.75M shs (2.513M by Co.) @ $16.50 by SBC Warburg Dillon Read. 12/00, 3-for-2 split; 7/96, 2-for-1 split. FY'01 Qs are restated.

Industry: Medical Equipment, Supplies & Distribution (NEC)

1655 Roberts Boulevard N W
KENNESAW
GEORGIA 30144
US

People also watch

BTC/USD

104,922.50 Price
-1.550% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

ETH/USD

3,884.58 Price
-1.330% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

US100

21,990.10 Price
0.000% 1D Chg, %
Long position overnight fee -0.0243%
Short position overnight fee 0.0021%
Overnight fee time 22:00 (UTC)
Spread 1.8

Gold

2,637.23 Price
-0.340% 1D Chg, %
Long position overnight fee -0.0083%
Short position overnight fee 0.0001%
Overnight fee time 22:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading